plerixafor and Postoperative Complications
plerixafor has been researched along with Postoperative Complications in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Fang, MH; Gao, SJ; Gu, XY; Hu, Z; Meng, XD; Su, L; Wang, X; Yang, YG; Zou, J | 1 |
Alkhatib, B; David, N; Fréguin-Bouilland, C; Godin, M; Henry, JP; Lallemand, F; Plissonnier, D; Thuillez, C | 1 |
Other Studies
2 other study(ies) available for plerixafor and Postoperative Complications
Article | Year |
---|---|
Posttransplant blockade of CXCR4 improves leukemia complete remission rates and donor stem cell engraftment without aggravating GVHD.
Topics: Animals; Benzylamines; Chimerism; Cyclams; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred NOD; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, CXCR4; Stem Cells; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2021 |
Low molecular weight fucoidan prevents neointimal hyperplasia after aortic allografting.
Topics: Animals; Aorta; Arteriosclerosis; Benzylamines; Chemokine CXCL12; Chemokines, CXC; Cyclams; Endothelium, Vascular; Heterocyclic Compounds; Hyperplasia; Male; Molecular Weight; Polysaccharides; Postoperative Complications; Rats; Rats, Inbred BN; Rats, Inbred Lew; Receptors, CXCR4; Transplantation; Transplantation, Homologous; Tunica Intima | 2007 |